|
We can now see further evidence that near infrared light stimulation can positively influence beta amyloid production and this can have a significant impact on people with cognitive decline from neurodegenerative Alzheimer's and Parkinson's disease. Quietmind Fdn. is using these technologies in our current clinical trials. Call 610-940-0488 for details. 
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
QMF NewsOur team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. Archives
September 2020
Categories
All
|
||
RSS Feed
Our mission is to study, provide and promote drug-free, low-cost, noninvasive approaches to understanding and treating disorders that affect people's thinking, behavior, and movement.
Office HoursMonday & Thursday: 11am - 6pm
In-office and remote conferencing available |
Locations8120 Old York Road, Suite 140
Elkins Park, PA 19027 60 Sutton Place 1CN New York, NY 10024 1619 3rd Ave. Suite 202 New York, NY 10128 (clinical trial evaluation only) |
Telephone NumberFax Number215-359-0630
|
Support UsQuietMIND Foundation is a 501c3 charitable nonprofit. Donations are fully tax deductible. We work to provide services regardless of ability to pay, please help those who need help.
|
© 2020 Quietmind Foundation | All Rights Reserved | Quietmind Foundation is a not-for-profit 501(c)(3) organization.